{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:32:03Z","timestamp":1777555923468,"version":"3.51.4"},"reference-count":13,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Technology &amp; Therapeutics"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:p>Eversense is a long-term implantable continuous glucose monitoring (CGM) system. Difficulty in locating and removing implanted sensors is one of the issues limiting its use. We propose using near-infrared (NIR) light to locate implanted glucose sensors. NIR light was used to locate implanted glucose sensors in 30 patients (age 18\u201362 years) with type 1 diabetes who use Eversense sensors for CGM. Duration of sensor implantation was 10\u201340 weeks (median 12 weeks). Out of 30 patients with type 1 diabetes, the NIR light located the implanted sensor in 24 patients (success rate 80%) within 5\u2009s. Sensor implantation at the skin with tattoos and excessive freckles were two main reasons for failure to locate sensors using NIR. We report an innovative method to locate implanted glucose sensors in seconds, which would reduce the time significantly to remove the sensor.<\/jats:p>","DOI":"10.1089\/dia.2020.0023","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T10:16:42Z","timestamp":1581070602000},"page":"538-540","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["A Novel and Easy Method to Locate and Remove First Approved Long-Term Implantable Glucose Sensors"],"prefix":"10.1177","volume":"22","author":[{"given":"Halis Kaan","family":"Akturk","sequence":"first","affiliation":[{"name":"Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Brackett","sequence":"additional","affiliation":[{"name":"Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,6,30]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1525"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2017.0142"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0020"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0397"},{"key":"e_1_3_5_6_2","unstructured":"FDA: Eversense CGM Sensor Insertion and Removal Instructions. www.fda.gov\/media\/112159\/download (accessed December24 2019)."},{"key":"e_1_3_5_7_2","unstructured":"VeinViewer\u00ae Vision Specifications. www.delec.com.uy\/wp-content\/uploads\/2016\/02\/Especificaciones-T%C3%A9cnicas-Vision.pdf (accessed December26 2019)."},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.3390\/s19163573"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.3171\/2019.5.JNS19297"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2014.968582"},{"key":"e_1_3_5_11_2","first-page":"508","article-title":"In vitro spectral analysis of tattoo pigments","volume":"34","author":"Beute TC","year":"2008","unstructured":"Beute TC, , Miller CH, , Timko AL, , Ross EV: In vitro spectral analysis of tattoo pigments. Dermatol Surg, 2008; 34:508\u2013515.","journal-title":"Dermatol Surg"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1117\/1.2844710"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1117\/1.JBO.22.1.015006"},{"key":"e_1_3_5_14_2","unstructured":"AIST: Spectral Database for Organic Compounds SDBS. https:\/\/sdbs.db.aist.go.jp\/sdbs\/cgi-bin\/direct_frame_top.cgi (accessed December12 2019)."}],"container-title":["Diabetes Technology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/dia.2020.0023","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dia.2020.0023","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dia.2020.0023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:12:40Z","timestamp":1777399960000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/dia.2020.0023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1089\/dia.2020.0023"],"URL":"https:\/\/doi.org\/10.1089\/dia.2020.0023","relation":{},"ISSN":["1520-9156","1557-8593"],"issn-type":[{"value":"1520-9156","type":"print"},{"value":"1557-8593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,30]]}}}